Anti-free-flow valve

Information

  • Patent Grant
  • 11890451
  • Patent Number
    11,890,451
  • Date Filed
    Wednesday, March 4, 2020
    4 years ago
  • Date Issued
    Tuesday, February 6, 2024
    9 months ago
  • Inventors
    • Shoham; Oriya
  • Original Assignees
    • EITAN MEDICAL LTD.
  • Examiners
    • Patel; Shefali D
    Agents
    • The Roy Gross Law Firm, LLC
    • Gross; Roy
Abstract
An apparatus for delivering a fluid to a subject through infusion tubing (22). The apparatus includes a tube cassette (20) for receiving the infusion tubing. The tube cassette has an anti-free-flow valve (26) configured to (i) occlude the infusion tubing, and (ii) be actuated by a force external to the tube cassette to terminate the occlusion of the infusion tubing. The tube cassette is configured to be removably coupled to a pump (24). The pump is configured to, as part of a pumping cycle for delivering the fluid to the subject, repeatedly (a) actuate the anti-free-flow valve to terminate the occlusion of the infusion tubing, and subsequently (b) release the anti-free-flow valve to occlude the infusion tubing. Other applications are also described.
Description
FIELD OF THE INVENTION

The present invention relates generally to medical fluid-delivery devices, and more specifically to infusion pumps.


BACKGROUND

Pumps are often used in the medical industry for delivering fluids, e.g., drugs or diagnostic fluids, to subjects. One type of medical pump is an infusion pump, used to infuse a fluid into a subject's circulatory system via infusion tubing. Some infusion pumps include a valve, or system of valves, that may occlude flow within the infusion tubing by pressing on the outside of the fluid-filled infusion tubing. Often infusion pumps engage with the infusion tubing via tube cassette. A common safety feature of tube cassettes is an anti-free-flow valve that ensures that the infusion tubing is occluded in the event that the tube cassette is disengaged from the pump.


SUMMARY OF THE INVENTION

A tube cassette and infusion pump for delivering a fluid to a subject are provided, in accordance with some applications of the present invention. The tube cassette receives the infusion tubing and is removably couplable to the pump. The tube cassette comprises an anti-free-flow valve that occludes the infusion tubing and can be actuated by a force external to the tube cassette to terminate the occlusion. Thus, in the absence of the external force, i.e., in its rest-state, the anti-free-flow valve occludes the infusion tubing. The infusion pump, e.g., a volumetric infusion pump, or peristaltic infusion pump, delivers the fluid to the subject by repeatedly (a) pressing on the infusion tubing with a pressing surface so as to push fluid toward the subject and then (b) raising the pressing surface from pressing on the infusion tubing so as to intake more fluid from a fluid source. When the tube cassette is coupled to the pump, as part of a pumping cycle for delivering the fluid to the subject, the pump repeatedly (a) actuates the anti-free-flow valve to terminate the occlusion of the infusion tubing, and subsequently (b) releases the anti-free-flow valve, allowing it to return to its rest state and occlude the infusion tubing. Thus, the pump uses the anti-free-flow valve of the tube cassette to deliver the fluid from the fluid source to the subject.


For some applications, the tube cassette comprises a lever, the anti-free-flow valve being disposed on the load arm (further described hereinbelow) of the lever. The lever is spring-loaded so as to maintain the anti-free-flow valve occluding the infusion tubing. The anti-free-flow valve may be actuated to terminate the occlusion by a force applied to the effort arm (further described hereinbelow) of the lever, in opposition to the spring loading of the lever. The anti-free-flow valve may be manually actuated to terminate the occlusion by a user when the tube cassette is not coupled to the pump, e.g., by the user pressing on the effort arm of the lever in opposition of the spring loading. Additionally, the anti-free-flow valve may be actuated to terminate the occlusion by a force applied by the pump to the effort arm of the lever in opposition of the spring loading.


There is therefore provided, in accordance with some applications of the present invention, apparatus for delivering a fluid to a subject through infusion tubing, the apparatus including:

    • (A) a tube cassette configured to receive the infusion tubing and including an anti-free-flow valve configured to:
      • (i) occlude the infusion tubing, and
      • (ii) be actuated by a force external to the tube cassette to terminate the occlusion of the infusion tubing; and
    • (B) a pump:
      • (i) the tube cassette being configured to be removably coupled to the pump, and
      • (ii) the pump being configured to, as part of a pumping cycle for delivering the fluid to the subject, repeatedly (a) actuate the anti-free-flow valve to terminate the occlusion of the infusion tubing, and subsequently (b) release the anti-free-flow valve to occlude the infusion tubing.


For some applications, the pump includes a pressing surface configured to press on the infusion tubing when the tube cassette is coupled to the pump.


For some applications, the anti-free-flow valve is configured to occlude the infusion tubing in the absence of any force external to the tube cassette being applied to the anti-free-flow valve.


For some applications, the anti-free-flow valve is configured to be actuated by the subject to terminate the occlusion of the infusion tubing when the tube-cassette is not coupled to the pump.


For some applications, a length of the tube cassette is 2-20 cm.


For some applications, the pump includes at least one pump-valve disposed within the pump and configured to occlude the infusion tubing when the tube cassette is coupled to the pump.


For some applications, the at least one pump-valve is exactly one pump-valve, and is the only valve disposed within the pump when the tube cassette is not coupled to the pump.


For some applications:

    • (a) the pump includes a pressing surface configured to press on the infusion tubing when the tube cassette is coupled to the pump, the anti-free-flow valve being positioned to occlude the infusion tubing on a first side of the pressing surface when the tube cassette is coupled to the pump, and
    • (b) the pump-valve being positioned to occlude the infusion tubing on a second side, opposite the first side, of the pressing surface when the tube cassette is coupled to the pump.


For some applications, the pump is configured to deliver the fluid to the subject by repeatedly, sequentially:

    • (a) opening an upstream valve selected from the group consisting of: the pump-valve and the anti-free-flow valve,
    • (b) intaking the fluid from a fluid source by raising the pressing surface from pressing on the infusion tubing,
    • (c) closing the upstream valve so as to occlude the infusion tubing upstream of the pressing surface,
    • (d) terminating an occlusion of the infusion tubing that is downstream of the pressing surface by opening a downstream valve that is not the upstream valve and that is selected from the group consisting of: the pump-valve and the anti-free-flow valve, and
    • (e) pressing on the infusion tubing using the pressing surface.


For some applications, the anti-free-flow valve is configured to be actuated to terminate the occlusion of the infusion tubing, upon the force external to the tube cassette being applied at a location along the infusion tubing longitudinally displaced from a site where the anti-free-flow valve occludes the infusion tubing.


For some applications, the tube cassette further includes a lever, the anti-free-flow valve being

    • (a) disposed on the load arm of the lever, the lever being spring-loaded so as to maintain the anti-free-flow valve occluding the infusion tubing, and
    • (b) configured to be actuated to terminate the occlusion of the infusion tubing by the force external to the tube cassette being applied to the effort arm of the lever, in opposition to the spring loading.


For some applications, the anti-free-flow valve is configured to be actuated to terminate the occlusion of the infusion tubing by the external force having any of a range of values, the range of values including 50 N.


For some applications, the range of values includes 25 N.


For some applications, the range of values includes 1 N.


For some applications, the range of values includes 0.5 N.


There is further provided, in accordance with some applications of the present invention, apparatus for delivering a fluid to a subject through infusion tubing, the apparatus including:

    • a volumetric infusion pump including:
      • two valves each configured to occlude the infusion tubing and one of the two valves being an anti-free-flow valve, and
      • a plunger configured to press on the infusion tubing between the two valves.


There is further provided, in accordance with some applications of the present invention, apparatus for use with a pump and infusion tubing, the apparatus including:

    • a tube cassette
      • (A) configured to (i) receive infusion tubing and (ii) be removably coupled to a pump, and
      • (B) including (i) an anti-free-flow valve and (ii) a lever,
        • the anti-free-flow valve being:
          • (a) disposed on the load arm of the lever, the lever being spring-loaded so as to maintain the anti-free-flow valve occluding the infusion tubing when the infusion tubing is received within the tube cassette,
          • (b) configured to, when the tube cassette is not coupled to the pump, be manually actuated by a force applied to the effort arm of the lever, in opposition to the spring loading of the lever, to terminate the occlusion of the infusion tubing, and
          • (c) configured to, when the tube cassette is coupled to the pump, repeatedly (i) be actuated by a force applied by the pump to the effort arm of the lever, in opposition to the spring loading of the lever, to terminate the occlusion of the infusion tubing, and subsequently (ii) occlude the infusion tubing upon removal of the force.


For some applications, the anti-free-flow valve is configured to be actuated to terminate the occlusion of the infusion tubing by the force, applied manually or by the pump, having any of a range of values, the range of values including 50 N.


For some applications, the range of values includes 25 N.


For some applications, the range of values includes 1 N.


For some applications, the range of values includes 0.5 N.


The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic illustration of a tube cassette that is removably couplable to a pump, in accordance with some applications of the present invention;



FIGS. 2A-B are schematic illustrations showing the tube cassette and the pump before and after the tube cassette has been coupled to the pump, in accordance with some applications of the present invention;



FIGS. 3A-B are schematic illustrations showing the actuation and subsequent release of the anti-free-flow valve by the pump, in accordance with some applications of the present invention; and



FIGS. 4A-F are schematic illustrations depicting a pumping cycle of the pump, in accordance with some applications of the present invention.





DETAILED DESCRIPTION

Reference is now made to FIG. 1, which is a schematic illustration of a tube cassette 20, in accordance with some applications of the present invention. Tube cassette 20 receives infusion tubing 22 and is removably couplable to a pump 24 (shown in FIGS. 2A-B, 3A-B, and 4A-F), such that pump 24 engages with infusion tubing 22 via tube cassette 20. Tube cassette 20 comprises an anti-free-flow valve 26 that occludes infusion tubing 22 and can be actuated by a force external to tube cassette 20 to terminate the occlusion of infusion tubing 22. Thus, in the absence of any force external to tube cassette 20 being applied to anti-free-flow valve 26, i.e., anti-free-flow valve 26 is in a rest-state, anti-free-flow valve 26 occludes infusion tubing 22. Typically, when tube cassette 20 is not coupled to pump 24, such as is shown in FIG. 1, anti-free-flow valve 26 may be manually actuated by the subject to terminate the occlusion of infusion tubing 22, as is further described hereinbelow.


Typically, anti-free-flow valve 26 is actuated to terminate the occlusion of infusion tubing 22 upon the external force being applied at a location along the infusion tubing, represented by dashed line 28, that is longitudinally displaced from a site where anti-free-flow valve 26 occludes infusion tubing 22, represented by dashed line 30. For some applications, the longitudinal displacement of where the force is applied, e.g., of pressable actuator 32, from where the infusion tubing is occluded may be a distance D of at least 10 mm and/or less than 150 mm. Typically, tube cassette 20 comprises a pressable actuator 32 to which the external force used to actuate anti-free-flow valve 26 is applied. For example, when not coupled to pump 24, the subject may press on pressable actuator 32 in order to actuate anti-free-flow valve 26 to terminate the occlusion of infusion tubing 22.


For some applications, the longitudinal displacement of where the external force is applied, e.g., of pressable actuator 32, from the site where anti-free-flow valve 26 occludes infusion tubing 22, is achieved by tube cassette 20 comprising a lever 34. As is known in the field of mechanics, a first-class lever has a load arm and an effort arm positioned on either side of a fulcrum. Anti-free-flow valve 26 is disposed on, e.g., at the end of, a load arm 36 of lever 34 and pressable actuator 32 is disposed on, e.g., at the end of, an effort arm 38 of lever 34. A fulcrum 76 is disposed between load arm 36 and effort arm 38. Lever 34 is spring loaded, e.g., by a spring 40 positioned between a housing 42 of tube cassette 20 and pressable actuator 32, so as to maintain anti-free-flow valve 26 occluding infusion tubing 22. Anti-free-flow valve 26 is actuated to terminate the occlusion of infusion tubing 22 by the force external to tube cassette 20 being applied to effort arm 38 of lever 34, e.g., to pressable actuator 32 at the end of effort arm 38, in opposition to the spring loading.


Using a lever to displace (a) where the force is applied to actuate anti-free-flow valve 26 from (b) where the occlusion of infusion tubing 22 occurs, enables anti-free-flow valve 26 to be actuated to terminate the occlusion with relatively low force. For example, the force external to tube cassette 20 required to actuate anti-free-flow valve 26 can be as low as 1 N, e.g., 10 N, e.g., 20 N, e.g., 50 N, e.g., higher.


Reference is now made to FIGS. 2A-B, which are schematic illustrations showing tube cassette 20 and pump 24 before and after tube cassette 20 has been coupled to pump 24, in accordance with some applications of the present invention. Typically, pump 24 delivers the fluid to the subject from a fluid source via infusion tubing 22 by repeatedly pressing on infusion tubing 22 with a pressing surface and then raising the pressing surface from pressing on infusion tubing 22. For example, pump 24 may be a volumetric infusion pump, or a peristaltic infusion pump. FIG. 2A shows tube cassette 20 in position to be coupled to pump 24, by being inserted into pump 24, as represented by arrow 43. Within pump 24 is an anti-free-flow-valve-actuator 44 that is positioned to press on pressable actuator 32 when actuated to do so by pump 24. As part of the pumping cycle for delivering the fluid to the subject, pump 24 repeatedly (a) actuates anti-free-flow valve 26 to terminate the occlusion of infusion tubing 22, and subsequently (b) releases anti-free-flow valve 26 to occlude infusion tubing 22. That is, pump 24 uses anti-free-flow valve 26 to deliver the fluid from the fluid source to the subject.


Typically, pump 24 is a volumetric pump that delivers the fluid to the subject by controlling two valves that occlude the infusion tube on either side of a pressing surface that presses on the infusion tube (as further described hereinbelow with reference to FIGS. 4A-F). Pump 24 comprises a pressing surface 46, that presses on infusion tubing 22 and at least one, e.g., exactly one, pump-valve 48 which occludes infusion tubing 22. When tube cassette 20 is coupled to pump 24, anti-free-flow valve 26 is positioned to occlude infusion tubing 22 on a first side 50 of pressing surface 46, and pump-valve 48 is positioned to occlude infusion tubing 22 on a second side 52, opposite first side 50, of pressing surface 46. For some applications, pump-valve 48 is the only valve disposed within pump 24 when tube cassette 20 is not coupled to pump 24.


Using anti-free-flow valve 26 as a valve that is part of the delivery cycle saves space within tube cassette 20, as it is no longer necessary for tube cassette 20 to be long enough to accommodate an anti-free-flow valve, an upstream valve of the pump and a downstream valve of the pump. Rather anti-free-flow valve 26 is used as either the upstream or the downstream valve during the pumping cycle. Typically, a length L of tube cassette 20 is at least 2 cm and/or less than 20 cm.


Reference is now made to FIGS. 3A-B, which are schematic illustrations depicting the actuation and subsequent release of anti-free-flow valve 26 by pump 24, in accordance with some applications of the present invention. FIG. 3A shows the positioning of pressable actuator 32 at the end of effort arm 38 of lever 34, anti-free-flow-valve-actuator 44 and anti-free-flow valve 26 when tube cassette 20 is first coupled to pump 24. To actuate anti-free-flow valve 26 to remove the occlusion of infusion tubing 22, pump 24 actuates anti-free-flow-valve-actuator 44 to press on pressable actuator 32 at the end of effort arm 38, in opposition of the spring loading, e.g., in opposition of the spring force provided by spring 40. This pressing of pressable actuator 32 is represented by downward facing arrow 54 in FIG. 3B. As a result, load arm 36 moves in an opposite direction, represented by upward arrow 56 in FIG. 3B, thereby lifting anti-free-flow valve 26 away from infusion tubing 22 to terminate the occlusion of infusion tubing 22.


When anti-free-flow-valve-actuator 44 is moved, by pump 24, in an upward direction, represented by upward arrow 58 in FIG. 3A, anti-free-flow-valve-actuator 44 no longer presses on pressable actuator 32, thereby allowing the spring loading of lever 34 to push pressable actuator 32 back up to its starting position, and in turn, anti-free-flow valve 26 back down to its occluding position, represented by downward arrow 60 in FIG. 3A.


Reference is now made to FIGS. 4A-F, which are schematic illustrations depicting a pumping cycle of pump 24, in accordance with some applications of the present invention. To deliver the fluid to the subject, pump 24 repeatedly, sequentially, cycles through the different positions shown in FIGS. 4A-E. FIG. 4A shows pump 24 and tube cassette 20 in a starting position when tube cassette 20 is coupled to pump 24. Typically, pressing surface 46 starts in a position in which it is pressing down on infusion tubing 22. Pump-valve 48, which in this configuration is acting as an upstream valve, starts in an open position such that there is no occlusion of infusion tubing 22 upstream of pressing surface 46. Pump 24 intakes the fluid from a fluid source by increasing the volume of a pumping segment of infusion tubing 22 (i.e., the segment of infusion tubing 22 that is disposed between pump-valve 48 and anti-free-flow valve 26) by raising pressing surface 46 from pressing on infusion tubing 22. The raising of pressing surface 46 is represented by upward arrow 62 in FIG. 4B. Subsequently to the intake of the fluid, pump 24 closes the upstream valve, i.e., pump-valve 48, so as to occlude infusion tubing 22 upstream of pressing surface 46, as represented by downward arrow 64 in FIG. 4C.


Subsequently, pump 24 actuates anti-free-flow-valve-actuator to press on pressable actuator 32, thereby terminating the occlusion of infusion tubing 22 downstream of pressing surface 46. Downward arrow 66 in FIG. 4D represents anti-free-flow-valve-actuator 44 pressing downward, and upward arrow 68 in FIG. 4D represents anti-free-flow valve 26 terminating the occlusion of infusion tubing 22 downstream of pressing surface 46.


Subsequently, pump 24 actuates pressing surface 46 to press on infusion tubing 22 to push the fluid to the subject, represented by downward arrow 70 in FIG. 4E. Subsequently, anti-free-flow-valve-actuator 44 is lifted, represented by upward arrow 72 in FIG. 4F, and anti-free-flow valve 26 resumes its occlusion of infusion tubing 22, represented by downward arrow 74 in FIG. 4F. Upon the completion of the pumping cycle, the upstream valve, i.e., pump-valve 48, is opened so as to terminate the occlusion upstream of pressing surface 46, thereby returning pump 24 to the starting position of FIG. 4A (in which pressing surface 46 is pressing on infusion tubing 22 and pump-valve 48 is open), in preparation for the intake of fluid for the next pumping cycle.


It is noted that in the configuration depicted, pump-valve 48 acts as the upstream valve, and anti-free-flow valve 26 acts as the downstream valve. This, however, is non-limiting, and it is within the scope of the present invention for pump-valve 48 to be positioned as the downstream valve and anti-free-flow valve 26 to be positioned as the upstream valve when tube cassette 20 is coupled to pump 24.


It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims
  • 1. An apparatus for delivering a fluid to a subject through infusion tubing, the apparatus comprising: (A) a tube cassette configured to receive the infusion tubing and comprising an anti-free-flow valve configured to: (i) occlude the infusion tubing, and(ii) be actuated by a force external to the tube cassette to terminate the occlusion of the infusion tubing, upon the force external to the tube cassette being applied at a location along the infusion tubing longitudinally displaced from a site where the anti-free-flow valve occludes the infusion tubing; and(B) a pump: (i) the tube cassette being configured to be removably coupled to the pump, the pump comprising a pressing surface configured to press on the infusion tubing when the tube cassette is coupled to the pump, and(ii) the pump being configured to, as part of a pumping cycle for delivering the fluid to the subject, repeatedly (a) actuate the anti-free-flow valve to terminate the occlusion of the infusion tubing, and subsequently (b) release the anti-free-flow valve to occlude the infusion tubing, wherein the anti-free-flow valve is configured to occlude the infusion tubing by moving in the same direction as the direction in which the pressing surface presses on the infusion tubing.
  • 2. The apparatus according to claim 1, wherein the anti-free-flow valve is configured to occlude the infusion tubing in an absence of any force external to the tube cassette being applied to the anti-free-flow valve.
  • 3. The apparatus according to claim 1, wherein the anti-free-flow valve is configured to be actuated by the subject to terminate the occlusion of the infusion tubing when the tube cassette is not coupled to the pump.
  • 4. The apparatus according to claim 1, wherein a length of the tube cassette is 2-20 cm.
  • 5. The apparatus according to claim 1, wherein the pump comprises at least one pump-valve disposed within the pump and configured to occlude the infusion tubing when the tube cassette is coupled to the pump.
  • 6. The apparatus according to claim 5, wherein the at least one pump-valve is exactly one pump-valve, and is the only valve disposed within the pump when the tube cassette is not coupled to the pump.
  • 7. The apparatus according to claim 5, wherein: (a) the anti-free-flow valve being positioned to occlude the infusion tubing on a first side of the pressing surface when the tube cassette is coupled to the pump, and(b) the at least one pump-valve being positioned to occlude the infusion tubing on a second side, opposite the first side, of the pressing surface when the tube cassette is coupled to the pump.
  • 8. The apparatus according to claim 7, wherein the pump is configured to deliver the fluid to the subject by repeatedly, sequentially: (a) opening an upstream valve selected from the group consisting of: the at least one pump-valve and the anti-free-flow valve,(b) intaking the fluid from a fluid source by raising the pressing surface from pressing on the infusion tubing,(c) closing the upstream valve so as to occlude the infusion tubing upstream of the pressing surface,(d) terminating an occlusion of the infusion tubing that is downstream of the pressing surface by opening a downstream valve that is not the upstream valve and that is selected from the group consisting of: the at least one pump-valve and the anti-free-flow valve, and(e) pressing on the infusion tubing using the pressing surface.
  • 9. The apparatus according to claim 1, wherein the tube cassette further comprises a lever, the anti-free-flow valve being (a) disposed on the load arm of the lever, the lever being spring-loaded so as to maintain the anti-free-flow valve occluding the infusion tubing, and(b) configured to be actuated to terminate the occlusion of the infusion tubing by the force external to the tube cassette being applied to the effort arm of the lever, in opposition to the spring-loading.
  • 10. The apparatus according to claim 9, wherein the anti-free-flow valve is configured to be actuated to terminate the occlusion of the infusion tubing by the force external to the tube cassette having any of a range of values, the range of values including 50 N.
  • 11. The apparatus according to claim 10, wherein the range of values includes 25 N.
  • 12. The apparatus according to claim 11, wherein the range of values includes 1 N.
  • 13. The apparatus according to claim 12, wherein the range of values includes 0.5 N.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is the US national stage application of PCT/IL2020/050249, filed Mar. 4, 2020, which published as PCT Publication WO 2020/178827 to Shoham, and which claims the priority of U.S. 62/814,053 to Shoham, filed Mar. 5, 2019 entitled, “Anti-free-flow valve,” which is incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/IL2020/050249 3/4/2020 WO
Publishing Document Publishing Date Country Kind
WO2020/178827 9/10/2020 WO A
US Referenced Citations (198)
Number Name Date Kind
3379950 Friedline Apr 1968 A
4236880 Archibald Dec 1980 A
4322668 Trussler et al. Mar 1982 A
4391600 Archibald Jul 1983 A
4650469 Berg et al. Mar 1987 A
5018945 D'Silva May 1991 A
5049047 Polaschegg et al. Sep 1991 A
5096385 Georgi et al. Mar 1992 A
5116203 Natwick et al. May 1992 A
5340951 Hungerbuhler et al. Aug 1994 A
5437642 Thill et al. Aug 1995 A
5567119 Johnson Oct 1996 A
5807075 Jacobsen et al. Sep 1998 A
5807322 Lindsey et al. Sep 1998 A
5843035 Bowman et al. Dec 1998 A
5954485 Johnson et al. Sep 1999 A
6312227 Davis Nov 2001 B1
6494864 Kerwin et al. Dec 2002 B1
6523414 Malmstrom et al. Feb 2003 B1
6531708 Malmstrom et al. Mar 2003 B1
6554806 Butterfield et al. Apr 2003 B2
6659976 Beck et al. Dec 2003 B2
6679862 Diaz et al. Jan 2004 B2
6702779 Connelly et al. Mar 2004 B2
6750468 Malmstrom et al. Jun 2004 B2
6852094 Beck et al. Feb 2005 B2
6889556 Steger May 2005 B2
6907788 Malmstrom et al. Jun 2005 B2
6908452 Diaz et al. Jun 2005 B2
6979311 Miles et al. Dec 2005 B2
7048715 Diaz et al. May 2006 B2
7059840 Corwin et al. Jun 2006 B2
7070575 Beck et al. Jul 2006 B2
7092796 Vanderveen Aug 2006 B2
7121143 Malmstrom et al. Oct 2006 B2
7163381 Barak Jan 2007 B1
7356382 Vanderveen Apr 2008 B2
7384408 Barak Jun 2008 B2
7497842 Diaz et al. Mar 2009 B2
7695448 Cassidy et al. Apr 2010 B2
7726174 Riley et al. Jun 2010 B2
7758551 Wiesner et al. Jul 2010 B2
7819838 Ziegler et al. Oct 2010 B2
7875004 Yodfat et al. Jan 2011 B2
7881883 Remde Feb 2011 B2
7892199 Mhatre et al. Feb 2011 B2
7896197 Furey et al. Mar 2011 B2
7921718 Malmstrom et al. Apr 2011 B2
7922700 Evans et al. Apr 2011 B2
7967773 Amborn et al. Jun 2011 B2
7981082 Wang et al. Jul 2011 B2
8025654 Barak Sep 2011 B2
8034020 Dewey Oct 2011 B2
8048022 Moy et al. Nov 2011 B2
8081069 Haueter et al. Dec 2011 B2
8105269 Zhou Jan 2012 B2
8142400 Rotem et al. Mar 2012 B2
8152780 Evans et al. Apr 2012 B2
8167832 Bowman et al. May 2012 B2
8182461 Pope et al. May 2012 B2
8197235 Davis Jun 2012 B2
8225639 Riley et al. Jul 2012 B2
8232484 Hauck Jul 2012 B2
8286505 Wade Oct 2012 B2
8287495 Michaud et al. Oct 2012 B2
8298184 Diperna et al. Oct 2012 B2
8328786 Strickler et al. Dec 2012 B2
8343111 Beck et al. Jan 2013 B2
8361021 Wang et al. Jan 2013 B2
8378837 Wang et al. Feb 2013 B2
8394051 Geipel Mar 2013 B2
8419676 Evans et al. Apr 2013 B2
8448523 Richter May 2013 B2
8486005 Yodfat et al. Jul 2013 B2
8486020 Hills et al. Jul 2013 B2
8496613 Zhou Jul 2013 B2
8539672 Eggers et al. Sep 2013 B2
8567235 Bojan et al. Oct 2013 B2
8641671 Michaud et al. Feb 2014 B2
8657778 Ziegler et al. Feb 2014 B2
8690014 Haueter et al. Apr 2014 B2
8690860 Abal Apr 2014 B2
8733178 Bivans et al. May 2014 B2
8752436 Beck et al. Jun 2014 B2
8758323 Michaud et al. Jun 2014 B2
8771227 Connelly et al. Jul 2014 B2
8795225 Lewis et al. Aug 2014 B2
8808230 Rotstein Aug 2014 B2
8821432 Unverdorben Sep 2014 B2
8852141 Mhatre et al. Oct 2014 B2
8859972 Cummings et al. Oct 2014 B2
8876787 Beck et al. Nov 2014 B2
8900213 Pope et al. Dec 2014 B2
8926561 Verhoef et al. Jan 2015 B2
8943894 Geipel Feb 2015 B2
8945064 Gravesen et al. Feb 2015 B2
8961453 Bowman et al. Feb 2015 B2
8974415 Robert et al. Mar 2015 B2
8986253 Diperna Mar 2015 B2
9004886 Beck et al. Apr 2015 B2
9005153 Kopperschmidt et al. Apr 2015 B2
9017296 Beck et al. Apr 2015 B2
9033923 Hartman et al. May 2015 B2
9101712 Denis et al. Aug 2015 B2
9109966 Duits Aug 2015 B2
9132230 Blomquist Sep 2015 B2
9162023 Barnes et al. Oct 2015 B2
9173998 Rosinko et al. Nov 2015 B2
9211377 Diperna et al. Dec 2015 B2
9227008 Magnenat et al. Jan 2016 B2
9234850 Hammond et al. Jan 2016 B2
9248230 Geipel et al. Feb 2016 B2
9272087 Halbert et al. Mar 2016 B2
9285324 Leuenberger Jockel Mar 2016 B2
9308323 Adams Apr 2016 B2
9375531 Lee et al. Jun 2016 B1
9408968 Browne et al. Aug 2016 B2
9415158 Miller et al. Aug 2016 B2
9427521 Pope et al. Aug 2016 B2
9468713 Hoenninger, III et al. Oct 2016 B2
9474854 Mhatre et al. Oct 2016 B2
9480793 Mhatre et al. Nov 2016 B2
9480794 Keith et al. Nov 2016 B2
9545478 Abal Jan 2017 B2
9561323 Plahey et al. Feb 2017 B2
9603998 Geipel et al. Mar 2017 B2
9610404 Rotstein Apr 2017 B2
9642777 Lewis et al. May 2017 B2
9662437 Moosai May 2017 B2
9675756 Kamen et al. Jun 2017 B2
9677555 Kamen et al. Jun 2017 B2
9682192 Marsh et al. Jun 2017 B2
9683562 Davis et al. Jun 2017 B2
9717849 Mhatre et al. Aug 2017 B2
9757517 Eberhard Sep 2017 B2
9770552 Hartman et al. Sep 2017 B2
9775947 Keith et al. Oct 2017 B2
9789251 Robert et al. Oct 2017 B2
9839744 Muto et al. Dec 2017 B2
9879668 Yavorsky et al. Jan 2018 B2
9901676 Mijers et al. Feb 2018 B2
9932977 Bresina et al. Apr 2018 B2
9937290 Connelly et al. Apr 2018 B2
9937291 Eberhard Apr 2018 B2
9958344 Burkhard May 2018 B2
9962486 Rosinko et al. May 2018 B2
9987424 Kim Jun 2018 B2
9995642 Shimoyama et al. Jun 2018 B2
10004847 Wander et al. Jun 2018 B2
10006453 Girard et al. Jun 2018 B2
10022494 Shimizu Jul 2018 B2
10022495 Halbert et al. Jul 2018 B2
10022496 Geipel et al. Jul 2018 B2
10046112 Oruklu et al. Aug 2018 B2
10080836 Juretich et al. Sep 2018 B2
10092697 Nessel et al. Oct 2018 B2
10112009 Dudar et al. Oct 2018 B2
10151646 Heo et al. Dec 2018 B2
10539453 Hauck Jan 2020 B2
11213460 O'Keefe et al. Jan 2022 B2
20030141468 Malmstrom et al. Jul 2003 A1
20050107923 Vanderveen May 2005 A1
20060173412 Susi Aug 2006 A1
20060189926 Hall et al. Aug 2006 A1
20060206054 Shekalim Sep 2006 A1
20070123781 Callahan et al. May 2007 A1
20070179435 Braig et al. Aug 2007 A1
20080283296 Zamora et al. Nov 2008 A1
20090221964 Rotem et al. Sep 2009 A1
20090240201 Rotem et al. Sep 2009 A1
20090293588 Riley et al. Dec 2009 A1
20100106082 Zhou Apr 2010 A1
20100114001 O'Mahony May 2010 A1
20100212407 Stringham et al. Aug 2010 A1
20100280446 Kalpin Nov 2010 A1
20110087165 Amborn et al. Apr 2011 A1
20110152772 Rotem et al. Jun 2011 A1
20110190606 Gable et al. Aug 2011 A1
20120205312 Hogard Aug 2012 A1
20120238949 Kalpin Sep 2012 A1
20120330574 Ruiter et al. Dec 2012 A1
20130035659 Hungerford et al. Feb 2013 A1
20130226129 Unverdorben Aug 2013 A1
20130336814 Kamen et al. Dec 2013 A1
20140066850 Robert et al. Mar 2014 A1
20140119954 Schweitzer et al. May 2014 A1
20140121639 Lowery et al. May 2014 A1
20140228755 Darrah et al. Aug 2014 A1
20150238689 Shimizu Aug 2015 A1
20150367120 Kusters et al. Dec 2015 A1
20180140770 Hetchler et al. May 2018 A1
20180200456 Eitan et al. Jul 2018 A1
20180318505 Eitan et al. Nov 2018 A1
20200085695 O'Keefe et al. Mar 2020 A1
20200282138 Eitan et al. Sep 2020 A1
20210178062 Eitan Jun 2021 A1
20210212903 O'Keefe et al. Jul 2021 A1
20210353507 O'Keefe et al. Nov 2021 A1
Foreign Referenced Citations (16)
Number Date Country
103727021 Apr 2014 CN
0182502 May 1986 EP
1381843 Mar 2009 EP
2040056 Sep 2010 EP
1381889 Mar 2016 EP
2570826 Aug 2016 EP
3834862 Jun 2021 EP
2553151 Apr 1985 FR
2150644 Jul 1985 GB
WO-9421918 Sep 1994 WO
02068018 Sep 2002 WO
2012126744 Sep 2012 WO
2019155453 Aug 2019 WO
2020060996 Mar 2020 WO
2020178824 Sep 2020 WO
2021146374 Jul 2021 WO
Non-Patent Literature Citations (11)
Entry
An Office Action dated Sep. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/740,365.
European Search Report dated Jun. 21, 2019 which issued during the prosecution of European Application No. 16817348.2.
An International Search Report and a Written Opinion both dated Aug. 5, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050409.
An Office Action dated Jun. 22, 2020, which issued during the prosecution of U.S. Appl. No. 15/740,365.
European Search Report dated Jun. 4, 2020, which issued during the prosecution of Applicant's European App No. 20160966.6.
An International Search Report and a Written Opinion both dated Jun. 9, 2020, which issued during the prosecution of Applicant's PCT/IL2020/050246.
European Search Report dated May 12, 2021 which issued during the prosecution of Applicant's European App No. 20212979.7.
U.S. Appl. No. 62/814,053, filed Mar. 5, 2019.
European Search Report dated Oct. 8, 2021 which issued during the prosecution of Applicant's European App No. 18905766.4.
Notice of Allowance dated Aug. 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/808,652.
An International Search Report and a Written Opinion both dated May 15, 2020, which issued during the prosecution of Applicant's PCT/IL2020/050249.
Related Publications (1)
Number Date Country
20220040405 A1 Feb 2022 US
Provisional Applications (1)
Number Date Country
62814053 Mar 2019 US